Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_128c60236db1023984beb979cde3e41c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
filingDate |
2002-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_875f1e2de49b33138d41b7d1a1c2b46e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921f3170bf2383a604324c0063738cad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_753c3c6e1200e4fa9a6a8bcd040a45d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d305ec74d34dca4676ca43ef4c7cd73b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f0758cb65afc577a4a9a42efd1b5b6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_761308ab0893b35a99f62e7ab8cbb4a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc217b66205fa2b6856cc92d4baca09c |
publicationDate |
2007-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7291720-B2 |
titleOfInvention |
Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections |
abstract |
The invention relates to the therapeutic or prophylactic treatment of fungal infections. The invention provides new methods for therapeutically or prophylactically treating fungal infections using sub-lethal concentrations of an anti-invasin compound. The methods according to the invention have fewer toxicology problems than existing methods, and thus can be used prophylactically, as well as for early treatment for high risk patients without a firm diagnosis. The methods according to the invention can also be used to treat an established fungal infection. The invention further provides novel genes that regulate fungal hyphal growth. |
priorityDate |
2000-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |